Clinical Trial Update: Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of Melasma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on the combination of arbutin, triamcinolone, and tretinoin for melasma shows Phase 2/3 status with suspension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Arbutin + Triamcinolone + Tretinoin

Snippet

Sponsor: Azidus Brasil | Conditions: Melasma | Phase 2, Phase 3 | Status: SUSPENDED